FRAT2


Summary: The protein encoded by this intronless gene belongs to the GSK-3-binding protein family. Studies show that this protein plays a role as a positive regulator of the WNT signaling pathway. It may be upregulated in tumor progression. [provided by RefSeq, Jul 2008].

NameOMIM IDEnsembl IDHGNC IDPHARMGKB IDMap Location
FRAT2, WNT signaling pathway regulatorMIM:605006Ensembl:ENSG00000181274HGNC:HGNC:16048PA2836210q24.1

GO terms in FRAT2


Term TypeEvidence TypeGO Term IDGO Des.
MFNDGO:0003674molecular_function
CCNDGO:0005575cellular_component
CCTASGO:0005829cytosol
BPNASGO:0007275multicellular organism development
BPNASGO:0008283cell proliferation
BPTASGO:1904886beta-catenin destruction complex disassembly

Gene expression in normal tissue: FRAT2

Gene-model tissue-cancer distribution: Bubble Plot

Gene-drug pathway distribution

Pathways in FRAT2


DatabasePathway IDPathway Des.
reactomeR-HSA-162582Signal Transduction
reactomeR-HSA-195253Degradation of beta-catenin by the destruction complex
reactomeR-HSA-195721Signaling by WNT
reactomeR-HSA-196299Beta-catenin phosphorylation cascade
reactomeR-HSA-201681TCF dependent signaling in response to WNT
reactomeR-HSA-4641262Disassembly of the destruction complex and recruitment of AXIN to the membrane
wikipathwaysWP428Wnt Signaling Pathway
kegghsa04310Wnt signaling pathway - Homo sapiens (human)
kegghsa05200Pathways in cancer - Homo sapiens (human)
kegghsa05224Breast cancer - Homo sapiens (human)
kegghsa05225Hepatocellular carcinoma - Homo sapiens (human)
kegghsa05226Gastric cancer - Homo sapiens (human)

Gene-Drug: Aster Plot


Drug IDDrug NameModel Num.
iGMDRD134Sorafenib2

Gene in drug-gene network: Network Plot

Gene-drug targets distribution

Gene Structure: PDB

Models in FRAT2

​​​​